title: [Therapy of obstructive respiratory tract diseases. II: Xanthines, calcium antagonists and VIP].
authors.forename: D
authors.initials: D
authors.lastname: Ukena
authors.forename: P
authors.initials: P
authors.lastname: Schlimmer
authors.forename: G W
authors.initials: GW
authors.lastname: Sybrecht
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D013806:Theophylline / Q000627:therapeutic use*; D014660:Vasoactive Intestinal Peptide / Q000627:therapeutic use*
chemical_list: D002121:Calcium Channel Blockers; D014660:Vasoactive Intestinal Peptide; D013806:Theophylline
vernacular_title: Die Therapie obstruktiver Atemwegserkrankungen. Teil II: Xanthine, Calciumantagonisten und VIP.